Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 6/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | CTSG | P08311 | 1/20 | 0.32 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10124682 | 0.91 | ELANE (0.38) | ELANEMAPTNPSR1ALDH1A1SLC6A2 | |
| SCHEMBL10124681 | 0.91 | ELANE (0.38) | ELANEMAPTNPSR1ALDH1A1SLC6A2 | |
| SCHEMBL10124677 | 0.90 | ELANE (0.39) | ELANEPGRALDH1A1CACNA1BAPBA1 | |
| SCHEMBL10124684 | 0.88 | TRIP13 (0.36) | CACNA1BAPBA1 | |
| SCHEMBL10124675 | 0.84 | ELANE (0.36) | ELANEPGRALDH1A1CACNA1BAPBA1 | |
| SCHEMBL18697264 | 0.81 | ELANE (0.35) | ELANEPGRALDH1A1CACNA1BAPBA1 | |
| SCHEMBL10124695 | 0.81 | ELANE (0.33) | ELANEMAPTNPSR1ALDH1A1CACNA1B | |
| SCHEMBL10124653 | 0.78 | ELANE (0.39) | ELANEPGRMAPTNPSR1GAA | |
| SCHEMBL10124678 | 0.78 | CACNA1B (0.35) | ELANEPGRNPSR1ALDH1A1CACNA1B | |
| SCHEMBL10124697 | 0.73 | GRM2 (0.35) | ELANEMAPTNPSR1ALDH1A1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9045480-B2 | Sterically hindered amine light stabilizers | BASF SE (DE) | 2015-06-02 | — | — | US | disclosed |
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | AAAS, CRY1, TAAR1 | ELANE 2936/4885PGR 2738/4885MAPT 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.